LOXAPINE Side Effects

6917651-2 | Catatonia
on Jul 27, 2010 Female patient from FRANCE , 14 years of age, was diagnosed with psychotic disorder (What is psychotic disorder?), muscle rigidity and was treated with Loxapine (View Usage). Patient experienced the following unwanted or unexpected effects: catatonia. Loxapine dosage: . During the same period patient was treated with HALOPERIDOL (View Haloperidol Review and Haloperidol Label ), TROPATEPINE (View Tropatepine Review and Tropatepine Label ). Patient was hospitalized.

6868685-8 | Urinary Retention
Patient was taking Loxapine (View Usage). Patient had the following side effects: urinary retention on Jul 21, 2010 from UNITED STATES Additional patient health information: Male patient , 32 years of age, weighting 200.0 lb, . Loxapine dosage: 200 Mg Daily Po.

6608695-9 | Oedema Peripheral
Adverse event was reported on Feb 24, 2010 by a Male patient taking Loxapine (View Usage) (Dosage: 20mg Po) . Location: UNITED STATES , 42 years of age, weighting 162.0 lb, After Loxapine was administered, patient had the following side effects: oedema peripheral. During the same period patient was treated with LEVOTHYROXINE (View Levothyroxine Review and Levothyroxine Label ), VITAMIN AND MINERAL PRENATAL SUPPLEMENT W/ FOLIC ACID CAP (View Vitamin And Mineral Prenatal Supplement W/ Folic Acid Cap Review and Vitamin And Mineral Prenatal Supplement W/ Folic Acid Cap Label ), AMANTADINE HCL (View Amantadine Hcl Review and Amantadine Hcl Label ), SEROQUEL (View Seroquel Review and Seroquel Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), LAMICTAL (View Lamictal Review and Lamictal Label ).

6600666-1 | Hypotension
on Feb 23, 2010 Female patient from UNITED STATES , 50 years of age, weighting 200.0 lb, was treated with Loxapine (View Usage). Patient experienced the following unwanted or unexpected effects: hypotension. Loxapine dosage: 25 Mg Tid Po.


6003167-7 | Mental Impairment, Neuroleptic Malignant Syndrome, Tremor
on Dec 12, 2008 Male patient from UNITED STATES , 66 years of age, weighting 163.0 lb, was diagnosed with delusion, paranoia and was treated with Loxapine (View Usage). Patient had the following side effects: mental impairment, neuroleptic malignant syndrome, tremor. Loxapine dosage: 20 Mg Bid Po.

5874962-X | Dyskinesia, Ill-defined Disorder, Jaw Disorder, Speech Disorder
Patient was taking Loxapine (View Usage). After Loxapine was administered, patient had the following side effects: dyskinesia, ill-defined disorder, jaw disorder, speech disorder on Sep 08, 2008 from UNITED STATES Additional patient health information: Male patient , 19 years of age, weighting 170.0 lb, was diagnosed with asperger's disorder and. Loxapine dosage: 25 Mg Bid Po. Patient was hospitalized.

5631341-8 |
Adverse event was reported on Feb 04, 2008 by a Male patient taking Loxapine (View Usage) (Dosage: ) . Location: UNITED STATES , 23 years of age, .

5572955-3 | Depressed Level Of Consciousness, Hyperhidrosis, Irritability, Muscle Rigidity, Pyrexia
on Dec 19, 2007 Male patient from UNITED STATES , weighting 175.0 lb, was treated with Loxapine (View Usage). Patient had the following side effects: depressed level of consciousness, hyperhidrosis, irritability, muscle rigidity, pyrexia. Loxapine dosage: 5mg Qid Po. During the same period patient was treated with RISPERIDONE (View Risperidone Review and Risperidone Label ), DOCUSATE (View Docusate Review and Docusate Label ), DULCOLAX (View Dulcolax Review and Dulcolax Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), OXAZEPAM (View Oxazepam Review and Oxazepam Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), VITAMIN CAP (View Vitamin Cap Review and Vitamin Cap Label ), DONEPEZIL HCL (View Donepezil Hcl Review and Donepezil Hcl Label ).

5572937-1 | Rash, Vomiting
on Dec 19, 2007 Male patient from UNITED STATES , 22 years of age, weighting 160.0 lb, was treated with Loxapine (View Usage). After Loxapine was administered, patient had the following side effects: rash (What is rash?), vomiting. Loxapine dosage: 10mg Po. During the same period patient was treated with ARIPIPRAZOLE (View Aripiprazole Review and Aripiprazole Label ), ALPRAZOLAM EXTENDED RELEASE (View Alprazolam Extended-release Review and Alprazolam Extended-release Label ), TOPIRAMATE (View Topiramate Review and Topiramate Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ), LORATADINE (View Loratadine Review and Loratadine Label ).

5566660-7 | Extrapyramidal Disorder, Head Lag, Muscle Rigidity, Neuroleptic Malignant Syndrome
Patient was taking Loxapine (View Usage). Patient experienced the following unwanted or unexpected effects: extrapyramidal disorder, head lag, muscle rigidity, neuroleptic malignant syndrome on Dec 18, 2007 from UNITED STATES Additional patient health information: Female patient , 63 years of age, weighting 120.0 lb, . Loxapine dosage: 5mg Tid Po. During the same period patient was treated with RISPERDAL (View Risperdal Review and Risperdal Label ), RISPERIDONE (View Risperidone Review and Risperidone Label ), BENZTROPINE (View Benztropine Review and Benztropine Label ), MACRODANTIN (View Macrodantin Review and Macrodantin Label ), CIPROFLOXACIN HCL (View Ciprofloxacin Hcl Review and Ciprofloxacin Hcl Label ), MOLINDONE HCL (View Molindone Hcl Review and Molindone Hcl Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ).

5566619-X | Hyperhidrosis, Screaming, Skin Discolouration, Stupor
Adverse event was reported on Dec 18, 2007 by a Female patient taking Loxapine (View Usage) (Dosage: 15mg Po) . Location: UNITED STATES , 63 years of age, weighting 178.0 lb, Patient had the following side effects: hyperhidrosis, screaming, skin discolouration, stupor. During the same period patient was treated with RISPERIDONE (View Risperidone Review and Risperidone Label ), BENZTROPINE (View Benztropine Review and Benztropine Label ), MACRODANTIN (View Macrodantin Review and Macrodantin Label ), CIPROFLOXACIN HCL (View Ciprofloxacin Hcl Review and Ciprofloxacin Hcl Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), MOBAN (View Moban Review and Moban Label ).

5242428-6 |
on Feb 01, 2007 Female patient from UNITED STATES , 52 years of age, was treated with Loxapine (View Usage). . Loxapine dosage: . During the same period patient was treated with FLURAZEPAM (View Flurazepam Review and Flurazepam Label ).

4598163-0 | Agitation, Hyperthyroidism, Hypoxia, Productive Cough, Pyrexia, Suicidal Ideation, Supraventricular Tachycardia, Temperature Regulation Disorder, Treatment Noncompliance
on Mar 01, 2005 Male patient from , 46 years of age, weighting 224.4 lb, was diagnosed with psychotic disorder (What is psychotic disorder?) and was treated with Loxapine (View Usage). Patient experienced the following unwanted or unexpected effects: agitation, hyperthyroidism, hypoxia, productive cough, pyrexia, suicidal ideation, supraventricular tachycardia, temperature regulation disorder, treatment noncompliance. Loxapine dosage: See Image. During the same period patient was treated with TRAVOPROST (View Travoprost Review and Travoprost Label ), .. (View .. Review and .. Label ), CLOTRIMAZOLE (View Clotrimazole Review and Clotrimazole Label ), BENZTROPINE MESYLATE (View Benztropine Mesylate Review and Benztropine Mesylate Label ). Patient was hospitalized.